Ian's Noesis Wiki

9 min read

Top 20 Companies in Global Artificial Retinal Implants Market (2026–2035): Expert View by Spherical Insights

RELEASE DATE:

Aug 2026 Author: Spherical Insights

According to a research report published by Spherical Insights & Consulting, the global Artificial retinal implants market size is projected to grow from USD 420 Million in 2025 to USD 972 Million by 2035, at a CAGR of 8.75% during the forecast period 2026–2035.

Description

According to a research report published by Spherical Insights & Consulting, the global Artificial retinal implants market size is projected to grow from USD 420 Million in 2025 to USD 972 Million by 2035, at a CAGR of 8.75% during the forecast period 2026–2035. The artificial retinal implant market demonstrates opportunity through AI-integrated bionic retina systems such as Argus II Retinal Prosthesis System, enhancing visual signal processing, improving patient adaptation, and strengthening adoption across advanced ophthalmic treatment settings globally.

Introduction

The artificial retinal implants market refers to medical devices designed to help people with severe retinal damage regain partial visual perception. The market includes epiretinal, subretinal, and suprachoroidal implants, based on their placement and stimulation methods. Market growth is driven by rising incidence of retinal disorders, the clinical necessity for vision restoration, innovations in implant material technology, device miniaturization, and enhanced surgical procedures. The introduction of advanced photovoltaic systems has significantly enlarged the market by incorporating wireless technology for retinal stimulation. A strategic collaboration between Science Corporation and Stanford University addresses the PRIMA retinal implant initiative, with Stanford University providing clinical research support and Science Corporation managing durability and product development. Furthermore, NIH-supported research continued advancing visual prosthesis technologies for vision restoration, supporting innovation in the artificial retinal implants market.

In April 2025, the U.S. National Eye Institute (NEI) funded researchers developing a new visual prosthesis using gold nanoparticles and a laser device to stimulate the retina. The research directly supports innovation in the artificial retinal implants market by exploring alternative approaches for restoring vision in patients with retinal disorders.

Market Segmentation

Global Artificial Retinal Implants Market Size, Share, By Product Type (Liquid Reagents, Dry Reagents, and Others), By Sample Type (Blood, Tissue, Cells, and Others), By Application (Clinical Diagnostics, Research, Biobanking, and Others), By End-User (Hospitals & Clinics, Research Institutes, Biobanks, Pharmaceutical & Biotechnology Companies, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2026 – 2035

Artificial Retinal Implants Market Size & Statistics

  • The Market Size for Artificial retinal implants Was Estimated to be worth USD 420 Million in 2025.

  • The Market is Going to Expand at a CAGR of 75% between 2026 and 2035.

  • The Global Artificial retinal implants Market Size is anticipated to reach USD 972 Million by 2035.

  • North America dominated the artificial retinal implants market in 2025 with approximately 47 %.

  • Asia Pacific is expected to grow at the fastest rate during the forecast period in the artificial retinal implants market.

Artificial retinal implants market

Regional growth and demand

Asia Pacific is expected to grow at the fastest rate during the forecast period in the artificial retinal implants market. The market’s expansion is attributed to several key drivers such as the increasing incidence of retinal conditions, greater investment in healthcare infrastructure, progress in bionic vision technology, and broader availability of specialized ophthalmic care. China leads regional advancement through ophthalmological research, medical device production, and innovations in vision restoration approaches. India facilitates growth by improving eye care facilities, raising awareness levels, and providing access to advanced retinal therapies. Japan and South Korea enhance regional development through technological innovation, clinical research, and retinal implant advancement.

North America is expected to generate the highest revenue during the forecast period in the artificial retinal implants market. The region’s dominance is driven by regulatory standards, efficient reimbursement structures, advanced clinical trial capabilities, and numerous specialized ophthalmology centers. The United States maintains a leading position in retinal implant research, cutting-edge surgical treatments, and the commercial development of vision restoration solutions. Canada facilitates market growth through specialized eye care services and research-driven programs. The clinical acceptance of vision implant technologies, increased patient accessibility, and robust healthcare expenditure collectively enhance demand for artificial retinal implants.

Top 10 Trends in the Artificial Retinal Implants Market

  • Increasing shift toward wireless power systems for enhanced device flexibility
  • Advancements in subretinal and suprachoroidal implant placement techniques
  • Integration of AI and adaptive image processing for improved visual interpretation
  • Development of high-density microelectrode arrays for better signal transmission
  • Growing combination of retinal implants with gene therapy approaches
  • Emergence of 3D-printed retinal tissues for regenerative applications
  • Rising strategic mergers and asset acquisitions to strengthen innovation pipelines
  • Increasing focus on age-related macular degeneration (AMD) treatment solutions
  • Expanding application of nanotechnology in retinal prosthetics development
  • Progress in cortical prosthetics enabling vision restoration beyond the eye
  1. Increasing shift toward wireless power systems for enhanced device flexibility

The artificial retinal implants market is witnessing greater adoption of wireless power technologies that reduce external wiring requirements, support compact implant designs, and enhance device convenience during daily activities.

  1. Advancements in subretinal and suprachoroidal implant placement techniques

Companies are advancing subretinal and suprachoroidal implantation techniques to improve surgical accuracy, electrode positioning, and device stability, supporting broader clinical adoption of artificial retinal implants and improving their suitability for patients with retinal degeneration.

  1. Integration of AI and adaptive image processing for improved visual interpretation

Artificial retinal implant manufacturers are integrating AI-based image processing to optimize electrical stimulation patterns, improve interpretation of visual signals, and enhance device performance, strengthening the development of more sophisticated vision restoration systems.

  1. Development of high-density microelectrode arrays for better signal transmission

The market is witnessing development of high-density microelectrode arrays that provide greater stimulation precision and increased retinal coverage, supporting improved visual resolution and encouraging manufacturers to develop next-generation artificial retinal implant platforms.

  1. Growing combination of retinal implants with gene therapy approaches

The artificial retinal implants market is exploring integration with gene therapy strategies to address retinal degeneration alongside electrical stimulation, creating opportunities for combination treatments and expanding the potential application of implantable technologies in vision restoration.

Top 20 Companies Leading the Artificial Retinal Implants Market

  1. Second Sight Medical Products

  2. Science Corporation

  3. Pixium Vision SA

  4. Nano Retina

  5. Retina Implant AG

  6. Bionic Vision Technologies (BVT)

  7. LambdaVision, Inc.

  8. Intelligent Implants Ltd

  9. iBIONICS

  10. Optobionics Corp

  11. Nidek Co., Ltd.

  12. Boston Retinal Implant Project

  13. Axorus

  14. Intelligent Medical Implants (IMI)

  15. Vivani Medical

  16. GenSight Biologics

  17. Medtronic

  18. Abbott Laboratories

  19. Bionic Eye Technologies

  20. CorNeat Vision

  21. Second Sight Medical Products

Headquarters: Sylmar, California, United States.

Second Sight Medical Products maintained a considerable presence in the artificial retinal implant market by developing the Argus II Retinal Prosthesis System, which obtained FDA clearance for use in individuals with retinitis pigmentosa. To enhance its vision technology line, the company engineered the Orion Visual Cortical Prosthesis System to circumvent impaired retinal components and stimulate the visual cortex. Second Sight completed the Early Feasibility Study for Orion in 2025, concluding a six-year development phase.

  1. Science Corporation

Headquarters: Alameda, California, United States.

Science Corporation is promoting advancement in the artificial retinal implants industry by developing the PRIMA Bionic Vision System, a wireless photovoltaic implant engineered for individuals with geographic atrophy stemming from dry age-related macular degeneration. The system operates through the application of near-infrared light emitted by specialized glasses to trigger the subretinal implant and generate visual perception. The company secured CE Mark approval for PRIMA in Europe in July 2026, representing a pivotal development in the commercialization process.

  1. Pixium Vision SA

Headquarters: Paris, France.

Pixium Vision SA made notable contributions to the artificial retinal implant industry through its PRIMA sub-retinal photovoltaic technology and IRIS II epiretinal implant systems. The company maintained its headquarters in Paris, France, and operated with 11-50 employees.The organization focused on bioelectronic, neuromodulation, and prosthetic vision technologies. Its research partnerships included the Institute of Vision, Stanford University, Moorfields Eye Hospital, and IMO Barcelona. The company directed its research efforts toward developing retinal prosthesis solutions in both Europe and the United States.

  1. Nano Retina

Headquarters: Herzliya, Israel.

Nano Retina developed the NR600 artificial retina, a technological innovation distinguished by its compact implant design, densely configured electrodes, nanotechnology-enhanced coatings, and infrared power supply system. The company was established in Herzliya, Israel, and maintained a workforce of 11–50 employees. The organization created medical technology for patients with retinal degenerative diseases, incorporating a subretinal implant and complementary eyeglasses. Nano Retina collaborated with multiple research institutions and organizations across the globe.

  1. Retina Implant AG

Headquarters: Reutlingen, Germany.

Retina Implant AG specialized in manufacturing subretinal micro photodiode implants based on Alpha IMS and Alpha AMS technologies for individuals experiencing hereditary retinal degeneration. The technology’s distinguishing feature was its use of photodiodes to detect light and initiate electrical impulses that enabled visual stimulation, contrasting with camera-based technologies. The Alpha AMS model incorporated approximately 1,600 photodiodes and demonstrated functional responses in clinical evaluations. The organization contributed substantially to knowledge regarding subretinal implant systems and surgical techniques, including OCT-based implant methodologies.

Are you ready to discover more about the artificial retinal implants market?

The report provides an in-depth analysis of the leading companies operating in the global artificial retinal implants market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

Company Profiles

  1. Second Sight Medical Products
  • Business Overview
  • Company Snapshot
  • Products Overview
  • Company Market Share Analysis
  • Company Coverage Portfolio
  • Financial Analysis
  • Recent Developments
  • Merger and Acquisitions
  • SWOT Analysis
  1. Science Corporation
  2. Pixium Vision SA
  3. Nano Retina
  4. Retina Implant AG
  5. Bionic Vision Technologies (BVT)
  6. LambdaVision, Inc.
  7. Intelligent Implants Ltd
  8. iBIONICS
  9. Others

Conclusion

The global artificial retinal implants market is experiencing steady expansion, supported by increasing retinal disorders, rising demand for vision restoration, and advancements in implant technologies. Market opportunities are emerging through wireless power systems, AI-based image processing, photovoltaic implants, high-density microelectrode arrays, and improved surgical approaches. North America continues to demonstrate strong market presence, while Asia Pacific is experiencing rapid growth due to improving healthcare capabilities. Leading companies such as Science Corporation, Second Sight Medical Products, Pixium Vision SA, Nano Retina, and Retina Implant AG are strengthening the market through technological development and innovative vision restoration solutions.

Graph View

Backlinks